PERSPECTA

News from every angle

← Back to headlines

Global Battle Rages for Dominance in Obesity Treatment Market

A fierce global battle is underway among European, American, and Chinese pharmaceutical companies to dominate the obesity treatment market. Novo Nordisk CEO Doustdar believes that no single player will monopolize this rapidly growing sector.

13 Aug, 15:24 — 13 Aug, 15:24
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed3d ago

Novo Nordisk CEO Doustdar says obesity drugs market won't be dominated by one player

Read full article →

Coverage Timeline

First report: seeking-alpha · 13 Aug, 15:24Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
seeking-alpha13 Aug, 15:24First to report

Novo Nordisk CEO Doustdar says obesity drugs market won't be dominated by one player

2h later
le-figaro13 Aug, 17:23Latest update

Labos européens, américains, chinois… La bataille mondiale des traitements contre l’obésité fait rage

Related Stories

Druckenmiller and Thiel Make Significant Investments in Major Tech Stock

1h ago

Wall Street Analysts Recommend High-Yield Dividend Stocks for Income

1h ago

SafePal Crypto Wallet Discloses Data Breach Affecting 40,000 Users

2h ago

Workday Acquisition Talks Could Reshape Software Industry

2h ago